Advertisement
Endocrinology

Targeting the Incretin Pathways in Type 2 Diabetes

05/28/2015

Ralph A. DeFronzo, MD, discusses the utilization of glucagon-like peptide-1 (GLP-1) agonists and incorporating evidence-based guidelines into practice when considering the use of incretin-based therapies for type 2 diabetes.

For mFor more videos, visit our partners at The Doctor's Channel.

Related Content

Gastroenterology
Gastroenterology
Mimics of IBD
08/01/2018
08/01/2018
Cardiovascular Diseases
Cardiovascular Diseases
Caught in the Act, Part 2
02/04/2005
02/04/2005
Gastroenterology
Gastroenterology
Clostridium Difficile in Active IBD: Which Came First and How Do You Treat?
08/06/2018
08/06/2018
Cardiology
Cardiology
Coronary Artery Calcium Density May Help Predict Risk of Heart Attack
06/04/2015
Michael H. Criqui, MD, discusses whether measuring calcium amount and density separately might better help predict if a person is at risk for developing a heart attack or stroke.
06/04/2015
Pediatric Gastroenterology
Daniel von Allmen, MD
Pediatric Gastroenterology
Daniel von Allmen, MD, on When to Consider Surgery in Pediatric Inflammatory Bowel Disease
07/16/2010
In this video, Daniel von Allmen, MD, from Cincinnati Children's Hospital, discusses when a clinician should consider surgery over systemic therapy for the treatment of pediatric inflammatory bowel...
07/16/2010